What is the current AI-Powered Drug Discovery Software market size?

The AI-Powered Drug Discovery Software market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the AI-Powered Drug Discovery Software market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the AI-Powered Drug Discovery Software market?

Key drivers include technological advancements, rising healthcare costs, and the need for efficient drug discovery processes.

What challenges does the AI-Powered Drug Discovery Software market face?

Challenges include high development costs, regulatory hurdles, and concerns over data privacy and security.

Which regions are leading the AI-Powered Drug Discovery Software market?

North America and Europe are currently leading the market due to strong healthcare infrastructure.

Who are the top companies in the AI-Powered Drug Discovery Software market?

Top companies include IBM, Microsoft, and Google, which offer advanced AI-powered solutions.

What future opportunities exist in the AI-Powered Drug Discovery Software market?

Future opportunities include increased adoption in emerging markets and the development of personalized medicine.

How will technology impact the AI-Powered Drug Discovery Software market?

Advances in machine learning and natural language processing will drive innovation and improve drug discovery efficiency.

What is the current regulatory landscape for the AI-Powered Drug Discovery Software market?

The regulatory landscape is evolving, with a focus on ensuring data privacy, security, and compliance with healthcare regulations.

What is the future outlook for the AI-Powered Drug Discovery Software market?

The future outlook is positive, with expected growth driven by increasing adoption and technological advancements.

AI-Powered Drug Discovery Software Market: Opportunity by 2034 | In-Depth Report

AI-Powered Drug Discovery Software by Application (Pharmaceutical Company, Academic Research Institution, Others), by Types (On-Premise, Cloud-Based), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

AI-Powered Drug Discovery Software Market Size | CAGR 15.2 Forecast 2033

AI-Powered Drug Discovery Software Market: Opportunity by 2034 | In-Depth Report

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

AI-Powered Drug Discovery Software Market Overview

The AI-Powered Drug Discovery Software market refers to the industry focused on developing and utilizing artificial intelligence and machine learning technologies to accelerate and enhance the process of discovering new drugs. As the AI-Powered Drug Discovery Software market size is projected to reach $4.3 billion by 2026, the growth outlook and market forecast indicate a significant expansion of the industry, driven by the increasing adoption of AI-powered solutions in pharmaceutical research. The market forecast suggests a compound annual growth rate (CAGR) of 24.5% from 2026 to 2033, with key drivers including technology shifts, regulatory support, and changing consumer behavior. The scope of the industry encompasses various synonyms, such as machine learning-based drug discovery, computational drug design, and predictive analytics for pharmaceutical research.

Loading chart…

The growth of the AI-Powered Drug Discovery Software market is influenced by several key forces, including technology shifts towards more advanced AI and machine learning algorithms, regulatory support for the adoption of AI in pharmaceutical research, and changing consumer behavior with increasing demand for personalized medicines. The largest region in the market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing investments in pharmaceutical research and development. As the industry continues to expand, strategic planners and business development teams must stay informed about the latest market trends and forecasts to make informed decisions and stay competitive in the AI-Powered Drug Discovery Software market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	3.83 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AtomWise; AutoDock; BenevolentAI; CCD Vault; Compound Assist; Cyclica; DrugDev Spark; DrugPatentWatch; DSG Drug Safety; Epocrates; InSilicoTrials; Insilico Medicine; Micro Tracker; PEPID PDC; Schrödinger; Thermo Scientific; XtalPi
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The AI-Powered Drug Discovery Software market is poised for significant growth, driven by increasing demand for innovative and efficient drug discovery solutions. The AI-Powered Drug Discovery Software market size is expected to expand rapidly, with a substantial growth forecast over the next five years.

Growth Drivers2 items

Advances in artificial intelligence and machine learning technologies are enabling the development of more sophisticated AI-Powered Drug Discovery Software, thereby driving market growth

Increasing research and development investments by pharmaceutical and biotechnology companies are fueling the adoption of AI-Powered Drug Discovery Software, contributing to the growth of the AI-Powered Drug Discovery Software market

Restraints2 items

High development costs and complexity associated with AI-Powered Drug Discovery Software are limiting their adoption, particularly among small and medium-sized pharmaceutical companies

Concerns regarding data privacy and security are hindering the widespread adoption of AI-Powered Drug Discovery Software, as pharmaceutical companies are hesitant to share sensitive data

Opportunities2 items

The increasing use of cloud-based platforms is creating new opportunities for the AI-Powered Drug Discovery Software market, as cloud-based solutions offer greater scalability and flexibility

The growing need for personalized medicine is driving the demand for AI-Powered Drug Discovery Software, as these solutions can help identify targeted treatments and improve patient outcomes

Challenges2 items

The lack of standardization in AI-Powered Drug Discovery Software is creating challenges for pharmaceutical companies, as it hinders the integration of different software solutions

The requirement for significant computational resources is a major challenge for the AI-Powered Drug Discovery Software market, as it increases the costs and complexity associated with software development and deployment

Market Segmentation

Loading chart…

The Application segment of the AI-Powered Drug Discovery Software market is a critical component of the overall market taxonomy. This segment is divided into subtypes, including target identification, lead generation, and optimization. Each subtype contributes to the overall market size, with target identification being the largest contributor. The application segment is crucial in understanding the AI-Powered Drug Discovery Software segmentation, as it provides insights into how the software is being utilized in various stages of the drug discovery process.

The Types segment of the AI-Powered Drug Discovery Software market refers to the different categories of software available, such as cloud-based and on-premise solutions. This segment is also divided into subtypes, including small molecule and biologics discovery software. Each subtype has its own unique characteristics and contributes to the overall market size. Understanding the types segment is essential in analyzing the market taxonomy, as it provides insights into the various software options available to pharmaceutical companies and research institutions.

AI-Powered Drug Discovery Software Segmentation Breakdown7 items

Application

Pharmaceutical Company

Academic Research Institution

Others

Types

On-Premise

Cloud-Based

Regional Insights

Loading chart…

The AI-Powered Drug Discovery Software market growth is anticipated to be driven by various regional factors. North America is the largest region, accounting for approximately 40% of the global market, driven by key factors such as high adoption rates of AI-powered technologies, favorable government policies, and significant investments in the pharmaceutical industry. Europe is the second-largest region, with a share of around 30%, driven by mature ecosystem, established infrastructure, and growing demand for innovative drug discovery solutions.

The Asia Pacific region is the fastest-growing region, with a projected regional forecast of 15% annual growth rate, driven by increasing demographics, rising healthcare expenditure, and growing investments in the pharmaceutical sector. Latin America and Middle East & Africa are also expected to witness significant growth, driven by growing adoption of AI-powered technologies, improving infrastructure, and increasing government initiatives to support the pharmaceutical industry.

Key Drivers by Region5 items

North America: high adoption rates, favorable government policies, significant investments

Europe: mature ecosystem, established infrastructure, growing demand

Asia Pacific: increasing demographics, rising healthcare expenditure, growing investments

Latin America: growing adoption, improving infrastructure, increasing government initiatives

Middle East & Africa: growing adoption, improving infrastructure, increasing government initiatives

Competitive Landscape

The AI-Powered Drug Discovery Software competitive landscape is moderately consolidated, with a mix of global players and local/regional companies. Key competitive levers include pricing, product innovation, and regulatory approvals. The market is driven by the need for efficient and effective drug discovery processes, with companies focusing on developing innovative solutions to stay ahead. The AI-Powered Drug Discovery Software competitive landscape is characterized by high competition, with companies employing various strategies to differentiate themselves.

Companies in this market are adopting common strategies such as partnerships, product launches, and expansion to gain a competitive edge. Competitive differentiation is achieved through technology, service model, and channel strength. However, companies face challenges such as margin pressure, compliance costs, and commoditization. To overcome these challenges, companies are focusing on strategic initiatives such as regional expansion, innovation pipeline, and cost advantages.

AtomWise: regional expansion

BenevolentAI: innovation pipeline

Cyclica: premium pricing

Schrödinger: OEM tie-ups

Thermo Scientific: local manufacturing

XtalPi: vertical integration

Key AI-Powered Drug Discovery Software Companies17 items

AtomWise

AutoDock

BenevolentAI

CCD Vault

Compound Assist

Cyclica

DrugDev Spark

DrugPatentWatch

DSG Drug Safety

Epocrates

InSilicoTrials

Insilico Medicine

Micro Tracker

PEPID PDC

Schrödinger

Thermo Scientific

XtalPi

Market Ecosystem

The AI-Powered Drug Discovery Software ecosystem spans across upstream, midstream, and downstream segments, involving various participants that create and capture value. Upstream, technology providers and suppliers deliver essential components, while midstream integrators and channels facilitate the development and distribution of software solutions. Downstream, end users, including pharmaceutical companies and research institutions, utilize these solutions to drive innovation in drug discovery.

Technology providers — develop AI-powered software

System integrators — configure and implement software solutions

Distributors — deliver software to end users

Service providers — offer maintenance and support services

Data/analytics providers — supply data for training AI models

Regulators/standards bodies — establish guidelines and standards

End users — utilize AI-powered software for drug discovery

In the AI-Powered Drug Discovery Software ecosystem, control points are primarily held by technology providers and regulators, as they influence the adoption and development of software solutions. Dependency risks arise from input constraints, such as data quality and availability, as well as standards and approvals from regulatory bodies. Switching costs and interoperability requirements can also impact the ecosystem, particularly in regions with diverse regulatory frameworks, highlighting the need for a thorough value chain analysis to navigate these complexities.

Recent Industry Insights

The AI-Powered Drug Discovery Software industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between pharmaceutical companies and AI technology providers have accelerated the adoption of AI-powered drug discovery solutions. Notable mergers and acquisitions have also taken place, with companies like Bayer and Microsoft investing heavily in AI-powered drug discovery platforms. Furthermore, several product launches have been announced, including the introduction of new machine learning algorithms and natural language processing capabilities. Regulatory changes, such as the FDA's guidance on the use of AI in drug development, have also had a profound impact on the industry. As a result, there has been a significant shift in consumer and enterprise trends, with a growing emphasis on personalized medicine and targeted therapies. Funding rounds and expansions have also been prevalent, with companies like Recursion Pharmaceuticals securing substantial investments to support their AI-powered drug discovery efforts.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the AI-Powered Drug Discovery Software market outlook is highly attractive, driven by the increasing demand for innovative pharmaceutical solutions. The competitive intensity is moderate, with key players investing heavily in research and development to stay ahead in the market.

The long-term outlook for this market is promising, with potential applications in personalized medicine and rare disease treatment. The innovation landscape is rapidly evolving, with advancements in machine learning and natural language processing. However, the demand-supply balance may be affected by regulatory challenges and data privacy concerns, which are key risk factors that need to be addressed.

11 items

1. Executive Summary

2. AI-Powered Drug Discovery Software Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global AI-Powered Drug Discovery Software Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global AI-Powered Drug Discovery Software Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmaceutical Company

6.1.2. Academic Research Institution

6.1.3. Others

6.2. Global AI-Powered Drug Discovery Software Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. On-Premise

6.2.2. Cloud-Based

6.3. Global AI-Powered Drug Discovery Software Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global AI-Powered Drug Discovery Software Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global AI-Powered Drug Discovery Software Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global AI-Powered Drug Discovery Software Market Competition by Key Manufacturers

8.1. Global AI-Powered Drug Discovery Software Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global AI-Powered Drug Discovery Software: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. AtomWise

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. AutoDock

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. BenevolentAI

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. CCD Vault

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Compound Assist

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Cyclica

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. DrugDev Spark

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. DrugPatentWatch

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. DSG Drug Safety

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Epocrates

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. InSilicoTrials

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Insilico Medicine

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Micro Tracker

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. PEPID PDC

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Schrödinger

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Thermo Scientific

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. XtalPi

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global AI-Powered Drug Discovery Software Market

Figure 4: Global AI-Powered Drug Discovery Software Market: Drivers

Figure 5: Global AI-Powered Drug Discovery Software Market: Challenges

Figure 6: Global AI-Powered Drug Discovery Software Market: Trends

Figure 7: Global AI-Powered Drug Discovery Software Market: Opportunity

Figure 8: Global AI-Powered Drug Discovery Software Market: Restraint

Figure 9: Global AI-Powered Drug Discovery Software Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global AI-Powered Drug Discovery Software Market Value (USD Million) By Region

Figure 15: Global AI-Powered Drug Discovery Software Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global AI-Powered Drug Discovery Software Market Value (USD Million) By Region

Figure 23: Global AI-Powered Drug Discovery Software Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

87 items

Table 1: Market Segmentation Analysis

Table 2: Global AI-Powered Drug Discovery Software Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global AI-Powered Drug Discovery Software Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global AI-Powered Drug Discovery Software Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global AI-Powered Drug Discovery Software Market Value (USD Million) By Region

Table 10: Global AI-Powered Drug Discovery Software Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global AI-Powered Drug Discovery Software Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global AI-Powered Drug Discovery Software Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global AI-Powered Drug Discovery Software Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: AtomWise Basic Information And Sales Area

Table 31: AtomWise. Products Portfolio

Table 32: AutoDock Basic Information And Sales Area

Table 33: AutoDock. Products Portfolio

Table 34: BenevolentAI Basic Information And Sales Area

Table 35: BenevolentAI. Products Portfolio

Table 36: CCD Vault Basic Information And Sales Area

Table 37: CCD Vault. Products Portfolio

Table 38: Compound Assist Basic Information And Sales Area

Table 39: Compound Assist. Products Portfolio

Table 40: Cyclica Basic Information And Sales Area

Table 41: Cyclica. Products Portfolio

Table 42: DrugDev Spark Basic Information And Sales Area

Table 43: DrugDev Spark. Products Portfolio

Table 44: DrugPatentWatch Basic Information And Sales Area

Table 45: DrugPatentWatch. Products Portfolio

Table 46: DSG Drug Safety Basic Information And Sales Area

Table 47: DSG Drug Safety. Products Portfolio

Table 48: Epocrates Basic Information And Sales Area

Table 49: Epocrates. Products Portfolio

Table 50: InSilicoTrials Basic Information And Sales Area

Table 51: InSilicoTrials. Products Portfolio

Table 52: Insilico Medicine Basic Information And Sales Area

Table 53: Insilico Medicine. Products Portfolio

Table 54: Micro Tracker Basic Information And Sales Area

Table 55: Micro Tracker. Products Portfolio

Table 56: PEPID PDC Basic Information And Sales Area

Table 57: PEPID PDC. Products Portfolio

Table 58: Schrödinger Basic Information And Sales Area

Table 59: Schrödinger. Products Portfolio

Table 60: Thermo Scientific Basic Information And Sales Area

Table 61: Thermo Scientific. Products Portfolio

Table 62: XtalPi Basic Information And Sales Area

Table 63: XtalPi. Products Portfolio

Table 64: Global Market Value (USD Million) (2025-2032) By Application

Table 65: Global Market Share (%) By Application (2032)

Table 66: Global Market Value (USD Million) (2025-2032) By Types

Table 67: Global Market Share (%) By Types (2032)

Table 68: Global AI-Powered Drug Discovery Software Market Value (USD Million) By Region

Table 69: Global AI-Powered Drug Discovery Software Market Share (%) By Region (2025-2032)

Table 70: North America Market Value (USD Million) (2025-2032) By Country

Table 71: North America Market Value (USD Million) (2025-2032) By Application

Table 72: North America Market Value (USD Million) (2025-2032) By Types

Table 73: Europe Market Value (USD Million) (2025-2032) By Country

Table 74: Europe Market Value (USD Million) (2025-2032) By Application

Table 75: Europe Market Value (USD Million) (2025-2032) By Types

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 79: South America Market Value (USD Million) (2025-2032) By Country

Table 80: South America Market Value (USD Million) (2025-2032) By Application

Table 81: South America Market Value (USD Million) (2025-2032) By Types

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 85: Research Programs/Design For This Report

Table 86: Key Data Information From Secondary Sources

Table 87: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

AI-Powered Drug Discovery Software Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	3.83 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	AtomWise; AutoDock; BenevolentAI; CCD Vault; Compound Assist; Cyclica; DrugDev Spark; DrugPatentWatch; DSG Drug Safety; Epocrates; InSilicoTrials; Insilico Medicine; Micro Tracker; PEPID PDC; Schrödinger; Thermo Scientific; XtalPi
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options